Article metrics

Download PDFPDF

Original article
Effect of tofacitinib on patient-reported outcomes in patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors in the phase III, randomised controlled trial: OPAL Beyond

 

Online download statistics by month:

Online download statistics by month: January 2019 to October 2024

AbstractFullPdf
Jan 201918718091
Feb 201918317573
Mar 20191039749
Apr 2019837743
May 2019908541
Jun 2019696236
Jul 2019605627
Aug 2019575221
Sep 2019494728
Oct 2019948842
Nov 2019624834
Dec 2019393516
Jan 2020332817
Feb 2020373618
Mar 2020373113
Apr 2020393327
May 2020463830
Jun 2020454258
Jul 2020423741
Aug 2020402825
Sep 2020463935
Oct 2020433844
Nov 2020413617
Dec 2020312418
Jan 2021352513
Feb 2021383418
Mar 2021494731
Apr 2021534233
May 2021474319
Jun 2021443524
Jul 2021413725
Aug 2021494716
Sep 2021353115
Oct 2021454143
Nov 2021282429
Dec 2021494126
Jan 2022181515
Feb 2022646149
Mar 2022776755
Apr 2022453728
May 2022595620
Jun 2022645625
Jul 2022716222
Aug 2022777715
Sep 2022494936
Oct 2022615923
Nov 2022685519
Dec 2022292921
Jan 2023404133
Feb 2023434116
Mar 2023443928
Apr 2023464323
May 2023393715
Jun 2023383213
Jul 2023332920
Aug 2023292216
Sep 2023333315
Oct 202311610818
Nov 202322422212
Dec 2023545230
Jan 2024382225
Feb 2024252116
Mar 2024272552
Apr 2024322637
May 2024333228
Jun 2024302518
Jul 2024342821
Aug 2024282525
Sep 2024404019
Oct 2024222419
Total379934491963